As of Apr 19
| -0.65 / -1.11%|
The 13 analysts offering 12-month price forecasts for Encompass Health Corp have a median target of 61.00, with a high estimate of 65.00 and a low estimate of 56.00. The median estimate represents a +4.90% increase from the last price of 58.15.
The current consensus among 14 polled investment analysts is to Buy stock in Encompass Health Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.